The Current Management of Esophageal Cancer

Advances in Surgery

Volumn 41, Issue , 2007, Pages 93-119

  Law, Simon ^a   Wong, John ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ADJUVANT THERAPY; ESOPHAGOSCOPY; ESOPHAGUS RESECTION; ESOPHAGUS TUMOR; HUMAN; METHODOLOGY; MULTIMODALITY CANCER THERAPY; PROGNOSIS; REVIEW;

ANTINEOPLASTIC AGENTS; COMBINED MODALITY THERAPY; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; ESOPHAGOSCOPY; HUMANS; PROGNOSIS; RADIOTHERAPY, ADJUVANT;

EID: 34548680299     PISSN: 00653411     EISSN: None     Source Type: Book Series    
DOI: 10.1016/j.yasu.2007.05.007     Document Type: Review

References (156)

1. Devesa S.S., Blot W.J., and Fraumeni Jr. J.F. Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer 83 (1998) 2049-2053
2. Lagergren J., Bergstrom R., Lindgren A., et al. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med 340 (1999) 825-831
3. Lagergren J., Bergstrom R., and Nyren O. Association between body mass and adenocarcinoma of the esophagus and gastric cardia. Ann Intern Med 130 (1999) 883-890
4. Sifrim D., and Zhang X. Pathophysiology of GERD in China: the same factors at a lower scale. Am J Gastroenterol 99 (2004) 2094-2097
5. Wong W.M., Lim P., and Wong B.C. Clinical practice pattern of gastroenterologists, primary care physicians, and otolaryngologists for the management of GERD in the Asia-Pacific region: the FAST survey. J Gastroenterol Hepatol 19 Suppl 3 (2004) S54-S60
6. Ho K.Y., Chan Y.H., and Kang J.Y. Increasing trend of reflux esophagitis and decreasing trend of Helicobacter pylori infection in patients from a multiethnic Asian country. Am J Gastroenterol 100 (2005) 1923-1928
7. Wong W.M., Lam S.K., Hui W.M., et al. Long-term prospective follow-up of endoscopic oesophagitis in southern Chinese-prevalence and spectrum of the disease. Aliment Pharmacol Ther 16 (2002) 2037-2042
8. Law S., Kwong D.L., Kwok K.F., et al. Improvement in treatment results and long-term survival of patients with esophageal cancer: impact of chemoradiation and change in treatment strategy. Ann Surg 238 (2003) 339-348
9. Siewert J.R., Stein H.J., Feith M., et al. Histologic tumor type is an independent prognostic parameter in esophageal cancer: lessons from more than 1,000 consecutive resections at a single center in the Western world. Ann Surg 234 (2001) 360-367
10. Hagen J.A., DeMeester S.R., Peters J.H., et al. Curative resection for esophageal adenocarcinoma: analysis of 100 en bloc esophagectomies. Ann Surg 234 (2001) 520-530
11. Altorki N., Kent M., Ferrara C., et al. Three-field lymph node dissection for squamous cell and adenocarcinoma of the esophagus. Ann Surg 236 (2002) 177-183
12. Ando N., Ozawa S., Kitagawa Y., et al. Improvement in the results of surgical treatment of advanced squamous esophageal carcinoma during 15 consecutive years. Ann Surg 232 (2000) 225-232
13. Birkmeyer J.D., Siewers A.E., Finlayson E.V., et al. Hospital volume and surgical mortality in the United States. N Engl J Med 346 (2002) 1128-1137
14. Birkmeyer J.D., Stukel T.A., Siewers A.E., et al. Surgeon volume and operative mortality in the United States. N Engl J Med 349 (2003) 2117-2127
15. Medical Research Council Oesophageal Cancer Working Party. Surgical resection with or without preoperative chemotherapy in oesophageal cancer: a randomised controlled trial. Lancet 359 (2002) 1727-1733
16. Bailey S.H., Bull D.A., Harpole D.H., et al. Outcomes after esophagectomy: a ten-year prospective cohort. Ann Thorac Surg 75 (2003) 217-222
17. Japanese Society of Esophageal Diseases. Comprehensive registry of esophageal cancer in Japan, 1999. Esophagus 2 (2005) 43-69
18. Law S. Esophageal cancer: current staging classifications and techniques, endoscopic ultrasound, laparoscopic and thoracoscopic staging. In: Yeo C, Peters JH, Dempsey DT, et al, editors. Shakelford's Surgery of the Alimentary Tract. 6th Edition. Volume 1. Part 6, Neoplasms of the esophagus. Chapter 33. Philadelphia, PA. 2007. p. 448-64.
19. Law S.Y., Fok M., and Wong J. Risk analysis in resection of squamous cell carcinoma of the esophagus. World J Surg 18 (1994) 339-346
20. Bartels H., Stein H.J., and Siewert J.R. Preoperative risk analysis and postoperative mortality of oesophagectomy for resectable oesophageal cancer. Br J Surg 85 (1998) 840-844
21. Law S., and Wong J. Does lymphadenectomy add anything to the treatment of esophageal cancer?. Adv Surg 33 (1999) 311-327
22. Law S., and Wong J. What is appropriate treatment for carcinoma of the thoracic esophagus?. World J Surg 25 (2001) 189-195
23. Orringer M.B., Marshall B., and Iannettoni M.D. Transhiatal esophagectomy: clinical experience and refinements. Ann Surg 230 (1999) 392-400
24. Katariya K., Harvey J.C., Pina E., et al. Complications of transhiatal esophagectomy. J Surg Oncol 57 (1994) 157-163
25. Hulscher J.B., van Sandick J.W., de Boer A.G., et al. Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagus. N Engl J Med 347 (2002) 1662-1669
26. Hulscher J.B., and van Lanschot J.J. Individualised surgical treatment of patients with an adenocarcinoma of the distal oesophagus or gastro-oesophageal junction. Dig Surg 22 (2005) 130-134
27. Cuschieri A., Shimi S., and Banting S. Endoscopic oesophagectomy through a right thoracoscopic approach. J R Coll Surg Edinb 37 (1992) 7-11
28. Law S. Minimally invasive techniques for oesophageal cancer surgery. Best Pract Res Clin Gastroenterol 20 (2006) 925-940
29. Law S., Fok M., Chu K.M., et al. Thoracoscopic esophagectomy for esophageal cancer. Surgery 122 (1997) 8-14
30. Yamamoto S., Kawahara K., Maekawa T., et al. Minimally invasive esophagectomy for stage I and II esophageal cancer. Ann Thorac Surg 80 (2005) 2070-2075
31. Law S.Y., Fok M., Wei W.I., et al. Thoracoscopic esophageal mobilization for pharyngolaryngoesophagectomy. Ann Thorac Surg 70 (2000) 418-422
32. Akaishi T., Kaneda I., Higuchi N., et al. Thoracoscopic en bloc total esophagectomy with radical mediastinal lymphadenectomy. J Thorac Cardiovasc Surg 112 (1996) 1533-1540
33. Collard J.M., Lengele B., Otte J.B., et al. En bloc and standard esophagectomies by thoracoscopy. Ann Thorac Surg 56 (1993) 675-679
34. Osugi H., Takemura M., Higashino M., et al. A comparison of video-assisted thoracoscopic oesophagectomy and radical lymph node dissection for squamous cell cancer of the oesophagus with open operation. Br J Surg 90 (2003) 108-113
35. Smithers B.M., Gotley D.C., McEwan D., et al. Thoracoscopic mobilization of the esophagus. A 6 year experience. Surg Endosc 15 (2001) 176-182
36. Luketich J.D., Alvelo-Rivera M., Buenaventura P.O., et al. Minimally invasive esophagectomy: outcomes in 222 patients. Ann Surg 238 (2003) 486-494
37. Nguyen N.T., Roberts P., Follette D.M., et al. Thoracoscopic and laparoscopic esophagectomy for benign and malignant disease: lessons learned from 46 consecutive procedures. J Am Coll Surg 197 (2003) 902-913
38. DePaula A.L., Hashiba K., Ferreira E.A., et al. Laparoscopic transhiatal esophagectomy with esophagogastroplasty. Surg Laparosc Endosc 5 (1995) 1-5
39. Swanstrom L.L. Minimally invasive surgical approaches to esophageal cancer. J Gastrointest Surg 6 (2002) 522-526
40. Bonavina L., Bona D., Binyom P.R., et al. A laparoscopy-assisted surgical approach to esophageal carcinoma. J Surg Res 117 (2004) 52-57
41. Martin D.J., Bessell J.R., Chew A., et al. Thoracoscopic and laparoscopic esophagectomy: initial experience and outcomes. Surg Endosc 19 (2005) 1597-1601
42. van den Broek W.T., Makay O., Berends F.J., et al. Laparoscopically assisted transhiatal resection for malignancies of the distal esophagus. Surg Endosc 18 (2004) 812-817
43. Palanivelu C., Prakash A., Senthilkumar R., et al. Minimally invasive esophagectomy: thoracoscopic mobilization of the esophagus and mediastinal lymphadenectomy in prone position-experience of 130 patients. J Am Coll Surg 203 (2006) 7-16
44. Espat N.J., Jacobsen G., Horgan S., et al. Minimally invasive treatment of esophageal cancer: laparoscopic staging to robotic esophagectomy. Cancer J 11 (2005) 10-17
45. Osugi H., Takemura M., Lee S., et al. Thoracoscopic esophagectomy for intrathoracic esophageal cancer. Ann Thorac Cardiovasc Surg 11 (2005) 221-227
46. Okushiba S., Ohno K., Itoh K., et al. Hand-assisted endoscopic esophagectomy for esophageal cancer. Surg Today 33 (2003) 158-161
47. Ikeda Y., Niimi M., Kan S., et al. Thoracoscopic esophagectomy combined with mediastinoscopy via the neck. Ann Thorac Surg 73 (2002) 1329-1331
48. Suzuki Y., Urashima M., Ishibashi Y., et al. Hand-assisted laparoscopic and thoracoscopic surgery (HALTS) in radical esophagectomy with three-field lymphadenectomy for thoracic esophageal cancer. Eur J Surg Oncol 31 (2005) 1166-1174
49. Bernabe K.Q., Bolton J.S., and Richardson W.S. Laparoscopic hand-assisted versus open transhiatal esophagectomy: a case-control study. Surg Endosc 19 (2005) 334-337
50. Del Genio A., Rossetti G., Napolitano V., et al. Laparoscopic esophagectomy in the palliative treatment of advanced esophageal cancer after radiochemotherapy. Surg Endosc 18 (2004) 1789-1794
51. Avital S., Zundel N., Szomstein S., et al. Laparoscopic transhiatal esophagectomy for esophageal cancer. Am J Surg 190 (2005) 69-74
52. Nakatsuchi T., Otani M., Osugi H., et al. The necessity of chest physical therapy for thoracoscopic oesophagectomy. J Int Med Res 33 (2005) 434-441
53. Fernando H.C., Luketich J.D., Buenaventura P.O., et al. Outcomes of minimally invasive esophagectomy (MIE) for high-grade dysplasia of the esophagus. Eur J Cardiothorac Surg 22 (2002) 1-6
54. Peracchia A., Rosati R., Fumagalli U., et al. Thoracoscopic dissection of the esophagus for cancer. Int Surg 82 (1997) 1-4
55. McAnena O.J., Rogers J., and Williams N.S. Right thoracoscopically assisted oesophagectomy for cancer. Br J Surg 81 (1994) 236-238
56. Cuschieri A. Thoracoscopic subtotal oesophagectomy. Endosc Surg Allied Technol 2 (1994) 21-25
57. Bumm R., Feussner H., Bartels H., et al. Radical transhiatal esophagectomy with two-field lymphadenectomy and endodissection for distal esophageal adenocarcinoma. World J Surg 21 (1997) 822-831
58. Kawahara K., Maekawa T., Okabayashi K., et al. Video-assisted thoracoscopic esophagectomy for esophageal cancer. Surg Endosc 13 (1999) 218-223
59. Gossot D., Cattan P., Fritsch S., et al. Can the morbidity of esophagectomy be reduced by the thoracoscopic approach?. Surg Endosc 9 (1995) 1113-1115
60. Dexter S.P., Martin I.G., and McMahon M.J. Radical thoracoscopic esophagectomy for cancer. Surg Endosc 10 (1996) 147-151
61. Shiraishi T., Kawahara K., Shirakusa T., et al. Risk analysis in resection of thoracic esophageal cancer in the era of endoscopic surgery. Ann Thorac Surg 81 (2006) 1083-1089
62. Taguchi S., Osugi H., Higashino M., et al. Comparison of three-field esophagectomy for esophageal cancer incorporating open or thoracoscopic thoracotomy. Surg Endosc 17 (2003) 1445-1450
63. Nguyen N.T., Follette D.M., Wolfe B.M., et al. Comparison of minimally invasive esophagectomy with transthoracic and transhiatal esophagectomy. Arch Surg 135 (2000) 920-925
64. Fukunaga T., Kidokoro A., Fukunaga M., et al. Kinetics of cytokines and PMN-E in thoracoscopic esophagectomy. Surg Endosc 15 (2001) 1484-1487
65. Bumm R., Holscher A.H., Feussner H., et al. Endodissection of the thoracic esophagus. Technique and clinical results in transhiatal esophagectomy. Ann Surg 218 (1993) 97-104
66. Leibman S., Smithers B.M., Gotley D.C., et al. Minimally invasive esophagectomy: short- and long-term outcomes. Surg Endosc 20 (2006) 428-433
67. Osugi H., Takemura M., Higashino M., et al. Learning curve of video-assisted thoracoscopic esophagectomy and extensive lymphadenectomy for squamous cell cancer of the thoracic esophagus and results. Surg Endosc 17 (2003) 515-519
68. Lam K.Y., Ma L.T., and Wong J. Measurement of extent of spread of oesophageal squamous carcinoma by serial sectioning. J Clin Pathol 49 (1996) 124-129
69. Law S., Arcilla C., Chu K.M., et al. The significance of histologically infiltrated resection margin after esophagectomy for esophageal cancer. Am J Surg 176 (1998) 286-290
70. Sagar P.M., Johnston D., McMahon M.J., et al. Significance of circumferential resection margin involvement after oesophagectomy for cancer. Br J Surg 80 (1993) 1386-1388
71. Dexter S.P., Sue-Ling H., McMahon M.J., et al. Circumferential resection margin involvement: an independent predictor of survival following surgery for oesophageal cancer. Gut 48 (2001) 667-670
72. Altorki N., and Skinner D. Should en bloc esophagectomy be the standard of care for esophageal carcinoma?. Ann Surg 234 (2001) 581-587
73. Clark G.W., Peters J.H., Ireland A.P., et al. Nodal metastasis and sites of recurrence after en bloc esophagectomy for adenocarcinoma. Ann Thorac Surg 58 (1994) 646-653
74. Portale G., Hagen J.A., Peters J.H., et al. Modern 5-year survival of resectable esophageal adenocarcinoma: single institution experience with 263 patients. J Am Coll Surg 202 (2006) 588-596
75. Johansson J., DeMeester T.R., Hagen J.A., et al. En bloc vs transhiatal esophagectomy for stage T3 N1 adenocarcinoma of the distal esophagus. Arch Surg 139 (2004) 627-631
76. Kodama M., and Kakegawa T. Treatment of superficial cancer of the esophagus: a summary of responses to a questionnaire on superficial cancer of the esophagus in Japan. Surgery 123 (1998) 432-439
77. Soetikno R., Kaltenbach T., Yeh R., et al. Endoscopic mucosal resection for early cancers of the upper gastrointestinal tract. J Clin Oncol 23 (2005) 4490-4498
78. Fujishiro M., Yahagi N., Kakushima N., et al. Endoscopic submucosal dissection of esophageal squamous cell neoplasms. Clin Gastroenterol Hepatol 4 (2006) 688-694
79. Stein H.J., Feith M., Bruecher B.L., et al. Early esophageal cancer: pattern of lymphatic spread and prognostic factors for long-term survival after surgical resection. Ann Surg 242 (2005) 566-573
80. Mariette C., Finzi L., Piessen G., et al. Esophageal carcinoma: prognostic differences between squamous cell carcinoma and adenocarcinoma. World J Surg 29 (2005) 39-45
81. Stein H.J., Feith M., Mueller J., et al. Limited resection for early adenocarcinoma in Barrett's esophagus. Ann Surg 232 (2000) 733-742
82. Akiyama H., Tsurumaru M., Udagawa H., et al. Radical lymph node dissection for cancer of the thoracic esophagus. Ann Surg 220 (1994) 364-372
83. Lerut T., Nafteux P., Moons J., et al. Three-field lymphadenectomy for carcinoma of the esophagus and gastroesophageal junction in 174 R0 resections: impact on staging, disease-free survival, and outcome: a plea for adaptation of TNM classification in upper-half esophageal carcinoma. Ann Surg 240 (2004) 962-972
84. Tachibana M., Kinugasa S., Yoshimura H., et al. Extended esophagectomy with 3-field lymph node dissection for esophageal cancer. Arch Surg 138 (2003) 1383-1389
85. Baba M., Aikou T., Natsugoe S., et al. Quality of life following esophagectomy with three-field lymphadenectomy for carcinoma, focusing on its relationship to vocal cord palsy. Dis Esophagus 11 (1998) 28-34
86. Law S.Y., Fok M., and Wong J. Pattern of recurrence after oesophageal resection for cancer: clinical implications. Br J Surg 83 (1996) 107-111
87. Dresner S.M., Wayman J., Shenfine J., et al. Pattern of recurrence following subtotal oesophagectomy with two field lymphadenectomy. Br J Surg 87 (2000) 362-373
88. Hulscher J.B., van Sandick J.W., Tijssen J.G., et al. The recurrence pattern of esophageal carcinoma after transhiatal resection. J Am Coll Surg 191 (2000) 143-148
89. Yano M., Takachi K., Doki Y., et al. Prognosis of patients who develop cervical lymph node recurrence following curative resection for thoracic esophageal cancer. Dis Esophagus 19 (2006) 73-77
90. Motoyama S., Kitamura M., Saito R., et al. Outcome and treatment strategy for mid- and lower-thoracic esophageal cancer recurring locally in the lymph nodes of the neck. World J Surg 30 (2006) 191-198
91. Kitagawa Y., Fujii H., Mukai M., et al. Sentinel lymph node mapping in esophageal and gastric cancer. Cancer Treat Res 127 (2005) 123-139
92. Tabira Y., Yasunaga M., Tanaka M., et al. Recurrent nerve nodal involvement is associated with cervical nodal metastasis in thoracic esophageal carcinoma. J Am Coll Surg 191 (2000) 232-237
93. Noguchi T., Wada S., Takeno S., et al. Two-step three-field lymph node dissection is beneficial for thoracic esophageal carcinoma. Dis Esophagus 17 (2004) 27-31
94. Yoshioka S., Fujiwara Y., Sugita Y., et al. Real-time rapid reverse transcriptase-polymerase chain reaction for intraoperative diagnosis of lymph node micrometastasis: clinical application for cervical lymph node dissection in esophageal cancers. Surgery 132 (2002) 34-40
95. Miyata H., Yano M., Doki Y., et al. A prospective trial for avoiding cervical lymph node dissection for thoracic esophageal cancers, based on intra-operative genetic diagnosis of micrometastasis in recurrent laryngeal nerve chain nodes. J Surg Oncol 93 (2006) 477-484
96. Fujita H., Kakegawa T., Yamana H., et al. Lymph node metastasis and recurrence in patients with a carcinoma of the thoracic esophagus who underwent three-field dissection. World J Surg 18 (1994) 266-272
97. Watanabe H., Kato H., and Tachimori Y. Significance of extended systemic lymph node dissection for thoracic esophageal carcinoma in Japan. Recent Results Cancer Res 155 (2000) 123-133
98. Tabira Y., Okuma T., Sakaguchi T., et al. Three-field dissection or two-field dissection?-A proposal of new algorithm for lymphadenectomy. Hepatogastroenterology 51 (2004) 1015-1020
99. Tachibana M., Kinugasa S., Yoshimura H., et al. Clinical outcomes of extended esophagectomy with three-field lymph node dissection for esophageal squamous cell carcinoma. Am J Surg 189 (2005) 98-109
100. Kato H., Watanabe H., Tachmimori Y., et al. Evaluation of neck lymph node dissection for thoracic esophageal carcinoma. Ann Thorac Surg 51 (1991) 931-935
101. Nishihira T., Hirayama K., and Mori S. A prospective randomized trial of extended cervical and superior mediastinal lymphadenectomy for carcinoma of the thoracic esophagus. Am J Surg 175 (1998) 47-51
102. Bumm R., and Wong J. Extent of lymphadenectomy in esophagectomy for squamous cell esophageal carcinoma: how much is necessary?. Dis Esophagus 7 (1994) 151-155
103. American Joint Committee on Cancer. Esophagus. In: Greene F.L. (Ed). AJCC cancer staging manual (2002), Springer Verlag, New York 91-95
104. Japanese Society for Esophageal Diseases. Guidelines for clinical and pathologic studies on carcinoma of the esophagus (2001), Kanehara & Co. Ltd.,, Tokyo
105. Launois B., Delarue D., Campion J.P., et al. Preoperative radiotherapy for carcinoma of the esophagus. Surg Gynecol Obstet 153 (1981) 690-692
106. Gignoux M., Roussel A., Paillot B., et al. The value of preoperative radiotherapy in esophageal cancer: results of a study of the E.O.R.T.C. World J Surg 11 (1987) 426-432
107. Wang M., Gu X.Z., Yin W.B., et al. Randomized clinical trial on the combination of preoperative irradiation and surgery in the treatment of esophageal carcinoma: report on 206 patients. Int J Radiat Oncol Biol Phys 16 (1989) 325-327
108. Arnott S.J., Duncan W., Kerr G.R., et al. Low dose preoperative radiotherapy for carcinoma of the oesophagus: results of a randomized clinical trial. Radiother Oncol 24 (1992) 108-113
109. Nygaard K., Hagen S., Hansen H.S., et al. Pre-operative radiotherapy prolongs survival in operable esophageal carcinoma: a randomized, multicenter study of pre-operative radiotherapy and chemotherapy. The second Scandinavian trial in esophageal cancer. World J Surg 16 (1992) 1104-1109
110. Ténière P., Hay J.-M., Fingerhut A., et al. Postoperative radiation therapy does not increase survival after curative resection for squamous cell carcinoma of the middle and lower esophagus as shown by a multicenter controlled trial. Surg Gynecol Obstet 173 (1991) 123-130
111. Fok M., Sham J.S., Choy D., et al. Postoperative radiotherapy for carcinoma of the esophagus: a prospective, randomized controlled study. Surgery 113 (1993) 138-147
112. Xiao Z.F., Yang Z.Y., Liang J., et al. Value of radiotherapy after radical surgery for esophageal carcinoma: a report of 495 patients. Ann Thorac Surg 75 (2003) 331-336
113. Arnott S.J., Duncan W., Gignoux M., et al. Oesophageal Cancer Collaborative Group. Preoperative radiotherapy for esophageal carcinoma. Cochrane Database Syst Rev 19 4 (2005) CD001799
114. Ando N., Iizuka T., Ide H., et al. Surgery plus chemotherapy compared with surgery alone for localized squamous cell carcinoma of the thoracic esophagus: a Japan Clinical Oncology Group Study-JCOG9204. J Clin Oncol 21 (2003) 4592-4596
115. Kelsen D.P., Ginsberg R., Pajak T.F., et al. Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer. N Engl J Med 339 (1998) 1979-1984
116. Cunningham D., Allum W.H., Stenning S.P., et al. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med 355 (2006) 11-20
117. Malthaner R., and Fenlon D. Preoperative chemotherapy for resectable thoracic esophageal cancer. Cochrane Database Syst Rev 19 3 (2006) CD001556
118. Herskovic A., Martz K., al Sarraf M., et al. Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus. N Engl J Med 326 (1992) 1593-1598
119. Cooper J.S., Guo M.D., Herskovic A., et al. Chemoradiotherapy of locally advanced esophageal cancer: long-term follow-up of a prospective randomized trial (RTOG 85-01). Radiation Therapy Oncology Group. JAMA 281 (1999) 1623-1627
120. Wong R., and Malthaner R. Combined chemotherapy and radiotherapy (without surgery) compared with radiotherapy alone in localized carcinoma of the esophagus. Cochrane Database Syst Rev (2004) CD002092
121. Le Prise E., Etienne P.L., Meunier B., et al. A randomized study of chemotherapy, radiation therapy, and surgery versus surgery for localized squamous cell carcinoma of the esophagus. Cancer 73 (1994) 1779-1784
122. Apinop C., Puttisak P., and Preecha N. A prospective study of combined therapy in esophageal cancer. Hepatogastroenterology 41 (1994) 391-393
123. Bosset J.F., Gignoux M., Triboulet J.P., et al. Chemoradiotherapy followed by surgery compared with surgery alone in squamous-cell cancer of the esophagus. N Engl J Med 337 (1997) 161-167
124. Lee J.L., Park S.I., Kim S.B., et al. A single institutional phase III trial of preoperative chemotherapy with hyperfractionation radiotherapy plus surgery versus surgery alone for resectable esophageal squamous cell carcinoma. Ann Oncol 15 (2004) 947-954
125. Urba S.G., Orringer M.B., Turrisi A., et al. Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma. J Clin Oncol 19 (2001) 305-313
126. Burmeister B.H., Smithers B.M., Gebski V., et al. Surgery alone versus chemoradiotherapy followed by surgery for resectable cancer of the oesophagus: a randomised controlled phase III trial. Lancet Oncol 6 (2005) 659-668
127. Walsh T.N., Noonan N., Hollywood D., et al. A comparison of multimodal therapy and surgery for esophageal adenocarcinoma. N Engl J Med 335 (1996) 462-467
128. Bedenne L., Michel P., Bouche O., et al. Chemoradiation followed by surgery compared with chemoradiation alone in squamous cancer of the esophagus. FFCD 9102. J Clin Oncol 25 (2007) 1160-1168
129. Bonnetain F., Bouche O., Michel P., et al. A comparative longitudinal quality of life study using the Spitzer quality of life index in a randomized multicenter phase III trial (FFCD 9102): chemoradiation followed by surgery compared with chemoradiation alone in locally advanced squamous resectable thoracic esophageal cancer. Ann Oncol 17 (2006) 827-834
130. Stahl M., Stuschke M., Lehmann N., et al. Chemoradiation with and without surgery in patients with locally advanced squamous cell carcinoma of the esophagus. J Clin Oncol 23 (2005) 2310-2317
131. Minsky B.D., Pajak T.F., Ginsberg R.J., et al. INT 0123 (Radiation Therapy Oncology Group 94-05) phase III trial of combined-modality therapy for esophageal cancer: high-dose versus standard-dose radiation therapy. J Clin Oncol 20 (2002) 1167-1174
132. Minsky B.D., Neuberg D., Kelsen D.P., et al. Final report of intergroup trial 0122 (ECOG PE-289, RTOG 90-12): phase II trial of neoadjuvant chemotherapy plus concurrent chemotherapy and high-dose radiation for squamous cell carcinoma of the esophagus. Int J Radiat Oncol Biol Phys 43 (1999) 517-523
133. Law S., and Wong J. Current management of esophageal cancer. J Gastrointest Surg 9 (2005) 291-310
134. Jones D.R., Parker L.A.J., Detterbeck F.C., et al. Inadequacy of computed tomography in assessing patients with esophageal carcinoma after induction chemoradiotherapy. Cancer 85 (1999) 1026-1032
135. Zuccaro G., Rice T.W., Goldblum J., et al. Endoscopic ultrasound cannot determine suitability for esophagectomy after aggressive chemoradiotherapy for esophageal cancer. Am J Gastroenterol 94 (1999) 906-912
136. Flamen P., Lerut A., Van Cutsem E., et al. Utility of positron emission tomography for the staging of patients with potentially operable esophageal carcinoma. J Clin Oncol 18 (2000) 3202-3210
137. Weber W.A., Ott K., Becker K., et al. Prediction of response to preoperative chemotherapy in adenocarcinomas of the esophagogastric junction by metabolic imaging. J Clin Oncol 19 (2001) 3058-3065
138. Wieder H.A., Brucher B.L., Zimmermann F., et al. Time course of tumor metabolic activity during chemoradiotherapy of esophageal squamous cell carcinoma and response to treatment. J Clin Oncol 22 (2004) 900-908
139. Law S., Kwong D.L.W., Wong K.H., et al. The effects of neoadjuvant chemoradiation on pTNM staging and its prognostic significance in esophageal cancer. J Gastrointest Surg 10 (2006) 1301-1311
140. Swisher S.G., Hofstetter W., Wu T.T., et al. Proposed revision of the esophageal cancer staging system to accommodate pathologic response (pP) following preoperative chemoradiation (CRT). Ann Surg 241 (2005) 810-817
141. Kitajima M., and Kitagawa Y. Surgical treatment of esophageal cancer-the advent of the era of individualization. N Engl J Med 347 (2002) 1705-1709
142. Lam K.Y., Law S., Ma L.T., et al. Pre-operative chemotherapy for squamous cell carcinoma of the oesophagus: do histological assessment and p53 overexpression predict chemo-responsiveness?. Eur J Cancer 33 (1997) 1221-1225
143. Walsh T.N., Grannell M., and Mansoor S. Predictive factors for success of neo-adjuvant therapy in upper gastrointestinal cancer. J Gastroenterol Hepatol 17 Suppl (2002) S172-S175
144. Sloof G.W. Response monitoring of neoadjuvant therapy using CT, EUS, and FDG-PET. Best Pract Res Clin Gastroenterol 20 (2006) 941-957
145. Ott K., Weber W.A., Lordick F., et al. Metabolic imaging predicts response, survival, and recurrence in adenocarcinomas of the esophagogastric junction. J Clin Oncol 24 (2006) 4692-4698
146. Suntharalingam M., Moughan J., Coia L.R., et al. The national practice for patients receiving radiation therapy for carcinoma of the esophagus: results of the 1996-1999 patterns of care study. Int J Radiat Oncol Biol Phys 56 (2003) 981-987
147. Baron T.H. Expandable metal stents for the treatment of cancerous obstruction of the gastrointestinal tract. N Engl J Med 344 (2001) 1681-1687
148. Dua K.S., Kozarek R., Kim J., et al. Self-expanding metal esophageal stent with anti-reflux mechanism. Gastrointest Endosc 53 (2001) 603-613
149. Laasch H.U., Marriott A., Wilbraham L., et al. Effectiveness of open versus antireflux stents for palliation of distal esophageal carcinoma and prevention of symptomatic gastroesophageal reflux. Radiology 225 (2002) 359-365
150. Homs M.Y., Wahab P.J., Kuipers E.J., et al. Esophageal stents with antireflux valve for tumors of the distal esophagus and gastric cardia: a randomized trial. Gastrointest Endosc 60 (2004) 695-702
151. Mayoral W., Fleischer D., Salcedo J., et al. Nonmalignant obstruction is a common problem with metal stents in the treatment of esophageal cancer. Gastrointest Endosc 51 (2000) 556-559
152. Law S., Tung P.H., Chu K.M., et al. Self-expanding metallic stents for palliation of recurrent malignant esophageal obstruction after subtotal esophagectomy for cancer. Gastrointest Endosc 50 (1999) 427-436
153. Lightdale C.J., Heier S.K., Marcon N.E., et al. Photodynamic therapy with porfimer sodium versus thermal ablation therapy with Nd:YAG laser for palliation of esophageal cancer: a multicenter randomized trial. Gastrointest Endosc 42 (1995) 507-512
154. Litle V.R., Luketich J.D., Christie N.A., et al. Photodynamic therapy as palliation for esophageal cancer: experience in 215 patients. Ann Thorac Surg 76 (2003) 1687-1692
155. Homs M.Y., Steyerberg E.W., Eijkenboom W.M., et al. Single-dose brachytherapy versus metal stent placement for the palliation of dysphagia from oesophageal cancer: multicentre randomised trial. Lancet 364 (2004) 1497-1504
156. Homs M.Y., Essink-Bot M.L., Borsboom G.J., et al. Quality of life after palliative treatment for oesophageal carcinoma-a prospective comparison between stent placement and single dose brachytherapy. Eur J Cancer 40 (2004) 1862-1871